Hinge Health (HNGE) CFO James Budge receives 65,000-share RSU equity grant

Rhea-AI Filing Summary

Hinge Health, Inc. reported that Chief Financial Officer James Budge received an award of 65,000 shares of Class A Common Stock in the form of restricted stock units. The RSU grant was acquired for no cash consideration and brings his directly held stake to 451,293 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Budge James

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	65,000	$0.00	--

Holdings After Transaction: Class A Common Stock — 451,293 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 65,000 shares Holdings after transaction: 451,293 shares Price per share: $0.0000 per share

3 metrics

RSU grant size 65,000 shares Restricted stock unit award to CFO James Budge

Holdings after transaction 451,293 shares Direct Class A Common Stock holdings post-award

Price per share $0.0000 per share Reported transaction price for RSU grant

Key Terms

restricted stock unit ("RSU"), Class A Common Stock, exempt transaction, grant, award, or other acquisition

4 terms

restricted stock unit ("RSU") financial

"Represents a restricted stock unit ("RSU") award that was acquired through an exempt transaction with the Issuer."

Class A Common Stock financial

"Each RSU represents a right to receive one share of the Issuer's Class A Common Stock at the time of vesting for no consideration."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

exempt transaction regulatory

"Represents a restricted stock unit ("RSU") award that was acquired through an exempt transaction with the Issuer."

grant, award, or other acquisition regulatory

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Budge James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	04/29/2026		A(1)		65,000	A	$0	451,293	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award that was acquired through an exempt transaction with the Issuer. Each RSU represents a right to receive one share of the Issuer's Class A Common Stock at the time of vesting for no consideration.

	/s/ James Budge	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Hinge Health (HNGE) disclose for James Budge?

Hinge Health disclosed that Chief Financial Officer James Budge received a grant of 65,000 restricted stock units. Each RSU converts into one share of Class A Common Stock upon vesting, increasing his direct holdings to 451,293 shares after the award.

Was the Hinge Health (HNGE) RSU grant to James Budge an open-market purchase?

No, the 65,000-share award was classified as a grant or other acquisition, not an open-market purchase. It was received for no cash consideration as part of equity compensation, using restricted stock units that vest into Class A Common Stock over time.

How many Hinge Health (HNGE) shares does James Budge hold after this Form 4?

Following the 65,000-share restricted stock unit grant, James Budge directly holds 451,293 shares of Hinge Health Class A Common Stock. This figure reflects his position immediately after the reported award, according to the Form 4 ownership disclosure.

What is a restricted stock unit (RSU) in the Hinge Health (HNGE) filing?

The filing states each restricted stock unit represents the right to receive one share of Class A Common Stock at vesting for no consideration. RSUs are a form of equity compensation that deliver actual shares only when vesting conditions are satisfied.

Does the Hinge Health (HNGE) Form 4 show any insider share sales by James Budge?

The Form 4 reflects only an acquisition via a 65,000-share RSU grant and no reported sales. Transaction coding and summary counts show one acquisition event and zero sell, gift, or tax-withholding transactions for this reporting period.